Description: Where licensed, Rayaldee® is indicated for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease stage 3 or 4 and vitamin D insufficiency or deficiency.
Be notified of any news, reports or updates straight to your email address
This site can be used to learn whether Rayaldee ® is available in your local market and to find out where you can go for further information. It will also direct you to useful educational resources on secondary hyperparathyroidism in chronic kidney disease.
Where licensed, Rayaldee ® is indicated for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease stage 3 or 4 and vitamin D insufficiency or deficiency. 1 Rayaldee ® is a registered trademark of EirGen Pharma Ltd.